Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 9/2006

01-09-2006 | Clinical Investigation

Added value of OCT in evaluating the presence of leakage in patients with age-related macular degeneration treated with PDT

Authors: M. E. J. van Velthoven, M. D. de Smet, R. O. Schlingemann, M. Magnani, F. D. Verbraak

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 9/2006

Login to get access

Abstract

Background

Evaluating the presence of leakage on fluorescein angiography (FA) in patients with age-related macular degeneration (AMD) retreated with photodynamic therapy (PDT) can be difficult. New diagnostic tools such as optical coherence tomography (OCT) might help to optimize PDT management.

Methods

Thirty AMD patients scheduled for regular follow-up FA in conjunction with PDT treatment were also scanned with OCT. Follow-up data at 9 months were retrieved from the patients’ medical records. Inter-observer agreement [kappa (κ) coefficient] for the presence of leakage on FA, for OCT parameters for leakage, and agreement between FA and OCT evaluations were calculated. The indication for retreatment was evaluated using the leakage analysis based on FA alone, OCT alone, and both examinations combined, and compared to the actual follow-up of the patients at 9 months.

Results

Agreement between the two observers for the presence of leakage on FA was moderate (κ=0.51). OCT agreement between the two observers for the presence of leakage was good (κ=0.85). Agreement between FA and OCT for the presence of leakage was poor (κ=0.16). Follow-up data at 9 months on all patients were analyzed. Seven out of 30 patients were not retreated at the time of examination, and four of these patients (57%) remained stable without further treatment. Twenty-three patients did receive a PDT treatment at the time of examination; and eight of these patients did not show leakage on OCT, and five of these patients (62%) remained stable without additional treatment. In contrast, only three out of 15 patients (20%) with leakage on both FA and OCT remained stable during this 9 month follow-up period.

Conclusions

Inter-observer agreement for the presence of leakage was moderate for FA and good for OCT. There was considerable disagreement between leakage as judged by OCT and by FA. OCT could be of help in the decision regarding PDT retreatment. Assuming that 57% of the patients without leakage either on FA or OCT would remain stable without retreatment, the rate of probable ineffective retreatment could be reduced from 35% to 20%.
Literature
1.
go back to reference Bellmann C, Miller DW, Mehltretter K, Schutt F, Jorzik J, Unnebrink K, Holz FG (2003) Digital analysis of choroidal neovascularisation in consecutive fluorescein angiograms for use in longitudinal clinical trials. Br J Ophthalmol 87:890–892CrossRefPubMed Bellmann C, Miller DW, Mehltretter K, Schutt F, Jorzik J, Unnebrink K, Holz FG (2003) Digital analysis of choroidal neovascularisation in consecutive fluorescein angiograms for use in longitudinal clinical trials. Br J Ophthalmol 87:890–892CrossRefPubMed
2.
go back to reference Bressler NM (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 119:198–207PubMed Bressler NM (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 119:198–207PubMed
3.
go back to reference Costa RA, Farah ME, Cardillo JA, Calucci D, Williams GA (2003) Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Retina 23:159–165CrossRefPubMed Costa RA, Farah ME, Cardillo JA, Calucci D, Williams GA (2003) Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Retina 23:159–165CrossRefPubMed
4.
go back to reference Friedman SM, Margo CE (2000) Choroidal neovascular membranes: reproducibility of angiographic interpretation. Am J Ophthalmol 130:839–841CrossRefPubMed Friedman SM, Margo CE (2000) Choroidal neovascular membranes: reproducibility of angiographic interpretation. Am J Ophthalmol 130:839–841CrossRefPubMed
5.
go back to reference Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP, Puliafito CA, Fujimoto JG (1995) Optical coherence tomography of the human retina. Arch Ophthalmol 113:325–332PubMed Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP, Puliafito CA, Fujimoto JG (1995) Optical coherence tomography of the human retina. Arch Ophthalmol 113:325–332PubMed
6.
go back to reference Hee MR, Baumal CR, Puliafito CA, Duker JS, Reichel E, Wilkins JR, Coker JG, Schuman JS, Swanson EA, Fujimoto JG (1996) Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 103:1260–1270PubMed Hee MR, Baumal CR, Puliafito CA, Duker JS, Reichel E, Wilkins JR, Coker JG, Schuman JS, Swanson EA, Fujimoto JG (1996) Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 103:1260–1270PubMed
7.
go back to reference Kaiser RS, Berger JW, Williams GA, Tolentino MJ, Maguire AM, Alexander J, Madjarov B, Margherio RM (2002) Variability in fluorescein angiography interpretation for photodynamic therapy in age-related macular degeneration. Retina 22:683–690CrossRefPubMed Kaiser RS, Berger JW, Williams GA, Tolentino MJ, Maguire AM, Alexander J, Madjarov B, Margherio RM (2002) Variability in fluorescein angiography interpretation for photodynamic therapy in age-related macular degeneration. Retina 22:683–690CrossRefPubMed
8.
go back to reference Montero JA, Ruiz-Moreno JM, Tavolato M (2003) Follow-up of age-related macular degeneration patients treated by photodynamic therapy with optical coherence tomography 3. Graefe’s Arch Clin Exp Ophthalmol 241:797–802CrossRefPubMed Montero JA, Ruiz-Moreno JM, Tavolato M (2003) Follow-up of age-related macular degeneration patients treated by photodynamic therapy with optical coherence tomography 3. Graefe’s Arch Clin Exp Ophthalmol 241:797–802CrossRefPubMed
9.
go back to reference Puliafito CA, Hee MR, Lin CP, Reichel E, Schuman JS, Duker JS, Izatt JA, Swanson EA, Fujimoto JG (1995) Imaging of macular diseases with optical coherence tomography. Ophthalmology 102:217–229PubMed Puliafito CA, Hee MR, Lin CP, Reichel E, Schuman JS, Duker JS, Izatt JA, Swanson EA, Fujimoto JG (1995) Imaging of macular diseases with optical coherence tomography. Ophthalmology 102:217–229PubMed
10.
go back to reference Rogers AH, Martidis A, Greenberg PB, Puliafito CA (2002) Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 134:566–576CrossRefPubMed Rogers AH, Martidis A, Greenberg PB, Puliafito CA (2002) Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 134:566–576CrossRefPubMed
11.
go back to reference TAP Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol 117:1329–1345 TAP Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol 117:1329–1345
Metadata
Title
Added value of OCT in evaluating the presence of leakage in patients with age-related macular degeneration treated with PDT
Authors
M. E. J. van Velthoven
M. D. de Smet
R. O. Schlingemann
M. Magnani
F. D. Verbraak
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 9/2006
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-005-0209-y

Other articles of this Issue 9/2006

Graefe's Archive for Clinical and Experimental Ophthalmology 9/2006 Go to the issue

Announcements

Announcements